Bajaj Finserv Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 0.37 %Nav, as on 12-12-2025

  • Previous Nav

  • Net Change on 12-12-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 -0.30 21.35 15.90 1.81 8,458.68
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 3.20 27.06 18.36 1.86 6,459.82
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 -0.18 20.77 15.92 1.93 2,812.12
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 -1.03 21.78 15.94 2.10 1,338.85
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 -1.23 23.83 15.73 2.25 1,126.13

Fund Holdings as on 30-November-2025

  • Divi's Laboratories Limited

  • Sun Pharmaceutical Industries Limited

  • Apollo Hospitals Enterprise Limited

  • Aurobindo Pharma Limited

  • Cipla Limited

  • Piramal Pharma Limited

  • Clearing Corporation of India Ltd

  • Neuland Laboratories Limited

  • Biocon Limited

  • Emcure Pharmaceuticals Limited

  • Fortis Healthcare Limited

  • Rubicon Research Limited

  • Lupin Limited

  • IPCA Laboratories Limited

  • Aurobindo Pharma Limited December 2025 Future

  • Glenmark Pharmaceuticals Limited

  • Pfizer Limited

  • Sanofi Consumer Healthcare India Limited

  • Shaily Engineering Plastics Limited

  • Vijaya Diagnostic Centre Limited

  • Zydus Wellness Limited

  • Godrej Consumer Products Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Dr. Lal Path Labs Limited

  • Abbott India Limited

  • Bajaj Finserv Money Market Fund-Direct Plan-Growth

  • Medi Assist Healthcare Services Limited

  • MedPlus Health Services Limited

  • Max Healthcare Institute Limited

  • Rainbow Childrens Medicare Limited

  • Hindustan Unilever Limited

  • Torrent Pharmaceuticals Limited

  • Jubilant Pharmova Limited

  • Alembic Pharmaceuticals Limited

  • Syngene International Limited

  • Tata Consumer Products Limited

  • Emami Limited

  • Mankind Pharma Limited

  • AstraZeneca Pharma India Limited

  • Eternal Limited

  • Marico Limited

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Household & Personal Products

  • Miscellaneous

  • Business Support

  • Plastic Products

  • Consumer Food

  • Retailing

  • Tea/Coffee

  • e-Commerce

  • Edible Oil

View More

Fund Manager

  • Cash

  • Derivatives

  • Equity

  • MFU

View More

About Bajaj Finserv Healthcare Fund

Scheme Analysis

Bajaj Finserv Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Bajaj Finserv Mutual Fund. It was launched on 27-Dec-2024 and currently has an AUM of ₹338.55 crore. Bajaj Finserv Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Bajaj Finserv Healthcare Fund ended up ₹0.04(0.37%)yesterday to ₹9.724.

Among its top 3 holdings the fund has exposure to Divi's Laboratories Limited, and

The Bajaj Finserv Healthcare Fund is managed by Nimesh Chandan and Siddharth Chaudhary.

Fund House Contact

S. No. 208/1B, Lohagaon Viman Nagar Pune - 411014

1800-309-3900
service@bajajamc.com
020-67672550